✦ LIBER ✦

Enoxaparin versus tinzaparin in non–ST-segment elevation acute coronary syndromes: Results of the enoxaparin versus tinzaparin (EVET) trial at 6 months

✍ Scribed by Christos Katsouras; Lampros K. Michalis; Nikos Papamichael; Kostas Adamides; Katerina K. Naka; Dimitris Nikas; John A. Goudevenos; Dimitris A. Sideris

Book ID: 116189899
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 237 KB
Volume: 150
Category: Article
ISSN: 1097-6744
DOI: 10.1016/j.ahj.2004.09.028

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Enoxaparin versus tinzaparin in non-ST–s

Enoxaparin versus tinzaparin in non-ST–segment elevation acute coronary syndromes: the EVET trial

✍ Lampros K Michalis; Christos S Katsouras; Nikos Papamichael; Kostas Adamides; Ka 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 104 KB

At six months, enoxaparin is more effect

At six months, enoxaparin is more effective than tinzaparin for people with non ST-segment elevation acute coronary syndromes

✍ Marc Cohen; Debbie Singh 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 67 KB

Weight-Based Dosing of Enoxaparin in Obe

Weight-Based Dosing of Enoxaparin in Obese Patients with Non-ST-Segment Elevation Acute Coronary Syndromes: Results from the CRUSADE Initiative

✍ Dr. Sarah A. Spinler; Ms. Fang-Shu Ou; Dr. Matthew T. Roe; Dr. W. Brian Gibler; 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 148 KB

PCV49 ENOXAPARIN VERSUS UNFRACTIONATED H

PCV49 ENOXAPARIN VERSUS UNFRACTIONATED HEPARIN FOR THE NONINVASIVE MANAGEMENT OF PATIENTS WITH NON-ST-SEGMENT ELEVATION ACUTE CORONARY SYNDROMES (NSTE-ACS): THE PHARMACOECONOMIC EVALUATION IN RUSSIA

✍ A Syrov; S Zyryanov; YB Belousov 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB

Randomized evaluation of the efficacy of

Randomized evaluation of the efficacy of enoxaparin versus unfractionated heparin in high-risk patients with non–ST-segment elevation acute coronary syndromes receiving the glycoprotein IIb/IIIa inhibitor eptifibatide. Long-term results of the Integrilin and Enoxaparin Randomized Assessment of Acute Coronary Syndrome Treatment (INTERACT) trial

✍ David H. Fitchett; Anatoly Langer; Paul W. Armstrong; Mary Tan; Aurora Mendelsoh 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 142 KB

Randomized double-blind safety study of

Randomized double-blind safety study of enoxaparin versus unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes treated with tirofiban and aspirin: The ACUTE II study

✍ Marc Cohen; Pierre Théroux; Steven Borzak; Martin J. Frey; Harvey D. White; W. V 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 115 KB